EUVIMEDEUVIMED entdecken
Crossref

Treatment with Roseburia intestinalis Relieves Symptoms of Chronic Kidney Disease (CKD) by Altering the Gut Microbiota and Increasing the Levels of Fecal SCFAs in Adriamycin-Induced CKD Rats

Jinna Xiao, Zhengqi Zha, Zhengzheng Liao, Zhentao Li

Current Microbiology · 2026

DOI: 10.1007/s00284-026-05084-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Jinna Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, People's Republic of …. Hauptthemen laut MEDLINE: Feces, Fatty Acids, Volatile, Gastrointestinal Microbiome, Renal Insufficiency, Chronic. Die Arbeit nennt 33 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, The Foundation of the Jiangxi Province Department of Science and Technology Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the therapeutic potential of the probiotic Roseburia intestinalis (R. intestinalis) in alleviating chronic kidney disease (CKD) symptoms and explored whether these effects are mediated through the modulation of the gut microbiota and fecal short-chain fatty acids (SCFAs). An Adriamycin (ADR)-induced CKD rat model was established, and the rats were treated with R. intestinalis via oral gavage for 8 weeks. Renal function, histopathology, and inflammatory markers were assessed. The gut microbiota composition was analyzed using 16 S rRNA sequencing, and SCFA levels were quantified by gas chromatography. To verify the underlying mechanism, fecal microbiota transplantation (FMT) was performed in germ-free CKD rats. The results demonstrate that R. intestinalis significantly mitigated CKD symptoms, including reduced proteinuria, serum creatinine, and renal inflammation, while reversing weight loss. The treatment restored gut microbial diversity, specifically by increasing the abundance of Firmicutes and fecal SCFA levels (acetate, propionate, and butyrate). Importantly, FMT from R. intestinalis-treated rats into germ-free CKD rats reversed these beneficial effects, whereas R. intestinalis alone under germ-free conditions was less effective, suggesting the need for a complex microbiome for full efficacy. These findings indicate that R. intestinalis is associated with alleviation of CKD symptoms by modulating the gut microbiota and enhancing fecal SCFA production, highlighting its potential as a promising probiotic intervention for CKD management and underscoring the role of the gut-kidney axis as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesFatty Acids, VolatileGastrointestinal MicrobiomeRenal Insufficiency, ChronicProbioticsAnimalsRatsMaleDoxorubicinFecal Microbiota TransplantationDisease Models, AnimalRats, Sprague-DawleyKidneyRNA, Ribosomal, 16S

Substanzen

Fatty Acids, VolatileDoxorubicinRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, People's Republic of China.
  • School of Life Science and Technology, State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjiaxiang Road, Nanjing, 210009, Jiangsu, People's Republic of China.
  • Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, People's Republic of China. ndyfy09785@ncu.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • The Foundation of the Jiangxi Province Department of Science and Technology Youth Project

Zitieren

APA

Xiao, J., Zha, Z., Liao, Z., & Li, Z. (2026). Treatment with Roseburia intestinalis Relieves Symptoms of Chronic Kidney Disease (CKD) by Altering the Gut Microbiota and Increasing the Levels of Fecal SCFAs in Adriamycin-Induced CKD Rats. Current Microbiology. https://doi.org/10.1007/s00284-026-05084-w

Vancouver

Xiao J, Zha Z, Liao Z, Li Z. Treatment with Roseburia intestinalis Relieves Symptoms of Chronic Kidney Disease (CKD) by Altering the Gut Microbiota and Increasing the Levels of Fecal SCFAs in Adriamycin-Induced CKD Rats. Current Microbiology. 2026. doi:10.1007/s00284-026-05084-w

BibTeX
@article{Xiao2026,
  author = {Xiao, Jinna and Zha, Zhengqi and Liao, Zhengzheng and Li, Zhentao},
  title = {Treatment with Roseburia intestinalis Relieves Symptoms of Chronic Kidney Disease (CKD) by Altering the Gut Microbiota and Increasing the Levels of Fecal SCFAs in Adriamycin-Induced CKD Rats},
  journal = {Current Microbiology},
  year = {2026},
  doi = {10.1007/s00284-026-05084-w}
}
Kostenlos starten →